HSIEN-YI CHIUHSIEN-CHING CHIU2022-01-112022-01-1120130098-7484https://www.scopus.com/inward/record.uri?eid=2-s2.0-84883664698&doi=10.1001%2fjama.2013.276214&partnerID=40&md5=f9c34d20db9f055cd279c88627bf09eahttps://scholars.lib.ntu.edu.tw/handle/123456789/592090[SDGs]SDG3corticosteroid; erlotinib; gefitinib; potassium hydroxide; acne; aged; article; cancer control; cancer staging; case report; clinical feature; drug efficacy; drug safety; drug substitution; drug withdrawal; dry skin; hair loss; human; lung adenocarcinoma; male; paronychia; priority journal; pruritus; pustule; treatment duration; Acneiform Eruptions; Aged; Aged, 80 and over; Biopsy; Drug Eruptions; Humans; Lung Neoplasms; Male; Quinazolines; Receptor, Epidermal Growth Factor; Scalpjournal article10.1001/jama.2013.276214240266032-s2.0-84883664698